JP3176984B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JP3176984B2 JP3176984B2 JP13432892A JP13432892A JP3176984B2 JP 3176984 B2 JP3176984 B2 JP 3176984B2 JP 13432892 A JP13432892 A JP 13432892A JP 13432892 A JP13432892 A JP 13432892A JP 3176984 B2 JP3176984 B2 JP 3176984B2
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- agar
- carrageenan
- weight
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 12
- 239000002775 capsule Substances 0.000 claims description 27
- 229920001817 Agar Polymers 0.000 claims description 16
- 239000008272 agar Substances 0.000 claims description 16
- 235000010419 agar Nutrition 0.000 claims description 16
- 235000010418 carrageenan Nutrition 0.000 claims description 13
- 239000000679 carrageenan Substances 0.000 claims description 13
- 229920001525 carrageenan Polymers 0.000 claims description 13
- 229940113118 carrageenan Drugs 0.000 claims description 13
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 13
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CKDZWMVGDHGMFR-UHFFFAOYSA-N Buttersaeure-cholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCC)C2 CKDZWMVGDHGMFR-UHFFFAOYSA-N 0.000 description 2
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- CKDZWMVGDHGMFR-GTPODGLVSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] butanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCC)C1 CKDZWMVGDHGMFR-GTPODGLVSA-N 0.000 description 2
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- KXWDMNPRHKRGKB-DYQRUOQXSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] heptanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCC)C1 KXWDMNPRHKRGKB-DYQRUOQXSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Liquid Crystal Substances (AREA)
Description
【０００１】本発明は塗布したときにカプセルのカス等
が残らず官能面で優れており、且つ美的外観をそなえ、
有効性を付加したカプセルとそれを液状物で覆うことを
特徴とする化粧料に関する。[0001] The present invention is excellent in a functional aspect without leaving capsule residue when applied, and has an aesthetic appearance.
It relates capsule and it was added effectiveness in cosmetics, characterized in that covered with liquid.
【０００２】[0002]
【従来の技術】従来、カプセルの成分としてゼラチン、
寒天やアルギン酸塩等が汎用されていた。しかしなが
ら、これらの成分では、皮膚に塗布時、カプセル剤がス
ムーズに溶解・破壊・展延せず、違和感がある。また、
液体中にカプセルを整然と一定間隔で配列した状態でこ
の混合系を維持するためには外相粘度を高くし、粘度で
カプセルを液中に均一分散させておく方法が行われてい
たが、この場合皮膚に塗布時、塗布感が重く伸展性が低
く、化粧品として問題があった。また、このような製剤
の場合、外観上も今までの化粧料とは異なっており、さ
らによりよい外観を求められている。2. Description of the Prior Art Conventionally, gelatin,
Agar, alginate and the like have been widely used. However, with these components, when applied to the skin, the capsule does not dissolve, break, or spread smoothly, giving a sense of incompatibility. Also,
In order to maintain this mixed system in a state where the capsules are arranged neatly at regular intervals in the liquid, a method of increasing the external phase viscosity and uniformly dispersing the capsules in the liquid with the viscosity has been used. When applied to the skin, the application feeling was heavy and the extensibility was low, and there was a problem as a cosmetic. In addition, in the case of such a preparation, the appearance is also different from conventional cosmetics, and an even better appearance is required.
【０００３】[0003]
【発明が解決しようとする課題】本発明の目的は皮膚に
適用したとき、カプセル剤がスムーズに破壊、展延し、
膜カスが残らず塗布感等に違和感がなく、製品として
も、美観を有し、且つ化粧品としての有効性を具備した
ものを提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a capsule which, when applied to the skin, breaks and spreads smoothly.
An object of the present invention is to provide a product which has no film residue, does not have a sense of incongruity in application feeling or the like, has a beautiful appearance as a product, and has effectiveness as a cosmetic.
【０００４】[0004]
【課題を解決するための手段】発明者らはすでに化粧
品、食用等で利用され、安全性が確認されている成分を
鋭意検討した結果、カプセル皮膜成分として寒天に親水
性造膜性の高分子であるカラゲーナンを配合するとカプ
セルの破壊・展延性、皮膚への違和感等の面で非常に有
用であることがわかった。すなわち本発明は、 （１）寒天を０．１〜５．０重量％で配合すると共に、
寒天とカラゲーナンとの配合比率が寒天を１に対してカ
ラゲーナンを２〜６の範囲で含むようにした皮膜成分か
らなるカプセルを含むことを特徴とする化粧料であり、 （２）上記カプセルに内包される成分がコレステリック
液晶である前記（１）記載の化粧料である。カラゲーナ
ンの種類はカッパ、イオタ、ラムダの３種類があるが特
に限定はないが、その中でもカッパ型が好ましいことも
分かった。すなわち、他の成分、寒天やカラゲーナンの
種類、或いは配合量によって変化するが寒天を１に対し
てカラゲーナン２〜６好ましくは３〜５、配合量も他の
成分、寒天やカラゲーナンの種類や配合比率によって変
化するが寒天を０．１〜５．０重量％、好ましくは０．
２〜０．５重量％、カラゲーナンを１．０〜５．０重量
％、好ましくは１．２〜１．６重量％を配合する。Means for Solving the Problems The inventors of the present invention have conducted intensive studies on components which have already been used in cosmetics, foods and the like and have been confirmed to be safe. It was found that the addition of carrageenan is very useful in terms of capsule breakage / spreadability, discomfort to the skin, etc. That is, the present invention provides: (1) Agar is compounded at 0.1 to 5.0% by weight,
The mixing ratio of agar to carrageenan is 1
Is the film component containing lagenan in the range of 2 to 6
A cosmetic comprising the Ranaru capsules, (2) before the component to be encapsulated in the capsule are cholesteric liquid crystal SL (1) cosmetic according. There are three types of carrageenan, kappa, iota, and lambda, but there is no particular limitation, but it was also found that the kappa type is preferable. That is, the amount of other components, agar or carrageenan, varies depending on the type of agar or carrageenan or the amount of agar, but the amount of agar is 2 to 6, preferably 3 to 5, and the amount of other components, the type of agar or carrageenan or the mixing ratio. The amount of agar is 0.1 to 5.0% by weight, preferably 0.1 to 5.0% by weight.
2 to 0.5% by weight, and 1.0 to 5.0% by weight of carrageenan, preferably 1.2 to 1.6% by weight.
【０００５】また、その他の化粧品原料として配合でき
る水溶性の原料は塗布感等に害を与えない範囲で利用で
きる。一方、カプセルの内包する物質として油溶性の物
質にするときは特にコレステリック液晶を利用するとそ
の外観の優位性や保湿性が有効に活かせる。コレステリ
ック液晶のなかでもコレステリル１２‐ヒドロキシステ
アレートを含むものが一番最適であった。液晶の組成は
特開平２−２２３５０６号、特願平１−４３２５５号、
特願平２−２３２５７３号のように作成すればよい。こ
れに加えて、アコヤ貝のステロール類等を加えるとさら
に有効である。[0005] Further, other water-soluble raw materials which can be blended as cosmetic raw materials can be used within a range that does not harm the feeling of application. On the other hand, when a cholesteric liquid crystal is used especially when an oil-soluble substance is contained as a substance to be encapsulated in the capsule, the superior appearance and moisture retention can be effectively utilized. Among the cholesteric liquid crystals, those containing cholesteryl 12-hydroxystearate were the most optimal. The composition of the liquid crystal is described in JP-A-2-223506, JP-A-1-43255,
What is necessary is just to create like Japanese Patent Application No. 2-232573. In addition to this, it is more effective to add sterols of pearl oysters.
【０００６】カプセルの形状は球形、楕円形、円筒形等
特に限定されない。内包物と外相がカプセルで隔てられ
ているため、成分間で作用しあい、劣化しやすいもの等
を分けて配合できるため、いろいろな利点が発生するこ
ともひとつの優位点である。さらに本カプセルはカプセ
ル皮膜が柔らかくカプセル皮膜を厚くしても使用感がよ
く、且つこの皮膜は透明性が高く皮膜率を高くすること
により、皮膜の厚さで物理的にカプセルが固定され、各
カプセルを一定間隔で整然として配合することができ、
外相粘度を最適に設定でき、塗布感等の官能性をよりよ
い状態に設定出来る。またカプセルの成形法はローター
ダイ式ソフトカプセル製造法、滴下法など公知の方法を
用いる。 The shape of the capsule is not particularly limited, such as a sphere, an ellipse, and a cylinder. One advantage is that since the inclusions and the external phase are separated by a capsule, they act between the components and can be easily mixed with those that are susceptible to deterioration, resulting in various advantages. Furthermore, this capsule has a soft feeling of use even if the capsule film is soft and the capsule film is thick, and this film has high transparency and high film ratio, so that the capsule is physically fixed at the film thickness, Capsules can be compounded regularly at regular intervals,
The external phase viscosity can be optimally set, and the functionality such as coating feeling can be set in a better state. A known method such as a rotor-die soft capsule manufacturing method or a dropping method is used for forming the capsule .
【０００７】（実施例１） カプセル剤 （重量％） 寒 天 ０．６％ カラゲーナン １．７％ 防腐剤 ０．１％ 精製水 ９７．６％ 内包物 コレステリル１２‐ヒドロキシステアレート ５０．０％ コレステリルヘプタノエート ２０．０％ コレステリルオレエート １５．０％ コレステリルブチレート １０．０％ ビタミンＥ ５．０％ 外 相 精製水 ８５．０％ ヒアルロン酸Ｎａ ０．２％ グリセリン １０．０％ １，３ブチレングリコール ４．７％ 防腐剤 ０．１％ （製造方法）カプセル剤、内包物、外相をそれぞれ別に
計量し撹拌しつつ溶解する。カプセル剤は７０℃、内包
物７５℃まで加熱する。カプセル剤２部と内包物１部を
二重オリフィスにより液中硬化法にてカプセルを成形す
る。これに外相を１部加える。(Example 1) Capsules (% by weight) Agar 0.6% Carrageenan 1.7% Preservative 0.1% Purified water 97.6% Inclusions Cholesteryl 12-hydroxystearate 50.0% Cholesteryl Heptanoate 20.0% Cholesteryl oleate 15.0% Cholesteryl butyrate 10.0% Vitamin E 5.0% External phase Purified water 85.0% Na hyaluronate 0.2% Glycerin 10.0% 1,3 Butylene glycol 4.7% Preservative 0.1% (Production method) Capsules, inclusions, and external phase are separately measured and dissolved with stirring. The capsules are heated to 70 ° C and the inclusions to 75 ° C. Capsules are molded from 2 parts of the capsule and 1 part of the inclusion by a double orifice in a liquid curing method. One part of the external phase is added to this.
【０００８】（実施例２） カプセル剤 （重量％） 寒 天 ０．３％ カラゲーナン １．０％ 防腐剤 ０．１％ 精製水 ９８．６％ 内包物 コレステリル１２‐ヒドロキシステアレート ４０．０％ コレステリルオレエート ３０．０％ コレステリルブチレート ２５．０％ アコヤ貝のステロール類 ５．０％ 外 相 精製水 ８７．９％ コンキオリン加水分解液（２．５％） ２．０％ グリセリン １０．０％ 防腐剤 ０．１％ （製造方法）実施例１と同じ方法で作成した。(Example 2) Capsules (% by weight) Agar 0.3% Carrageenan 1.0% Preservatives 0.1% Purified water 98.6% Inclusions Cholesteryl 12-hydroxystearate 40.0% Cholesteryl Oleate 30.0% Cholesteryl butyrate 25.0% Pearl shellfish sterols 5.0% External phase Purified water 87.9% Conchiolin hydrolyzate (2.5%) 2.0% Glycerin 10.0% Preservative Agent 0.1% (Production method) Prepared in the same manner as in Example 1.
【０００９】使用テスト 女性４名づつの顔面を左右に分け、一方を実施例、もう
一方を比較例として毎日、１回以上使用してもらって、
１月後、アンケートした。なお、比較例は 比較例１は実施例１のカラゲーナンを寒天に置き換えた
もの 比較例２は実施例１のコレステリック液晶をスクワラン
に置き換えたもの 比較例３は実施例２のカラゲーナンを寒天に置き換えた
もの 比較例４は実施例２のコレステリック液晶をスクワラン
に置き換えたもの なお、１６名を４班にわけ、下記の表１の試料を使って
実験した。Use test The face of each of four women was divided into left and right, one was used as an example, and the other was used as a comparative example, and used once or more daily.
A questionnaire was given a month later. Comparative Example 1 was obtained by replacing carrageenan of Example 1 with agar. Comparative Example 2 was obtained by replacing cholesteric liquid crystal of Example 1 with squalane. Comparative Example 3 was obtained by replacing carrageenan of Example 2 with agar. Comparative Example 4 was obtained by replacing the cholesteric liquid crystal of Example 2 with squalane. In addition, 16 persons were divided into 4 groups, and an experiment was performed using the samples shown in Table 1 below.
【００１０】[0010]
【表１】 判定基準は以下のようでアンケートの結果をまとめたの
が以下の表２である。 実施例の方が非常によい ３ 実施例の方がかなりよい ２ 実施例の方がややよい １ 差がない ０ 比較例の方がややよい −１ 比較例の方がかなりよい −２ 比較例の方が非常によい −３[Table 1] Table 2 below summarizes the results of the questionnaire with the following criteria. Example is much better 3 Example is much better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better -2 Comparative example Is much better -3
【００１１】[0011]
【表２】 [Table 2]
【００１２】化粧料として皮膚に適用したとき、カプセ
ル剤がスムースに破壊、展延し、膜カスが残らず、塗布
感に違和感がなく、又製品として極めて美観を呈する。 When applied to the skin as a cosmetic, the capsule is smoothly broken and spread, no film residue remains, the application feeling is not uncomfortable, and the product has a very beautiful appearance.
Claims (2)
と共に、寒天とカラゲーナンとの配合比率が寒天を１に
対してカラゲーナンを２〜６の範囲で含むようにした皮
膜成分からなるカプセルを含むことを特徴とする化粧
料。1. An agar blended at 0.1 to 5.0% by weight.
At the same time, the mixing ratio of agar and carrageenan reduces agar to 1
Skin containing carrageenan in the range of 2 to 6
Cosmetic characterized by including a capsule consisting of a membrane component
Fees .
テリック液晶である請求項１記載の化粧料。 2. The cosmetic according to claim 1 , wherein the component contained in the capsule is a cholesteric liquid crystal .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13432892A JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13432892A JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05310529A JPH05310529A (en) | 1993-11-22 |
| JP3176984B2 true JP3176984B2 (en) | 2001-06-18 |
Family
ID=15125763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13432892A Expired - Fee Related JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3176984B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190075186A (en) * | 2017-12-20 | 2019-07-01 | 주식회사 아이젤 | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340473B1 (en) * | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| US8741320B2 (en) * | 2003-08-27 | 2014-06-03 | Beiersdorf Ag | Spherical cosmetic preparations for topical application |
| JP2007503418A (en) * | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | Capsule with outer skin that becomes individually undetectable during topical use |
| JP2008174634A (en) * | 2007-01-18 | 2008-07-31 | Chisso Corp | Cholesteric liquid crystal composition |
| KR20230047217A (en) * | 2017-12-18 | 2023-04-06 | 엘브이엠에이취 러쉐르쉐 | Liquid cosmetic with agar shell capsule |
| KR102415878B1 (en) * | 2021-03-11 | 2022-06-30 | 주식회사 현대바이오랜드 | Colesteric liquid crystal-encapsulated complex coacervate particles and cosmetic composition comprising the same |
-
1992
- 1992-04-28 JP JP13432892A patent/JP3176984B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190075186A (en) * | 2017-12-20 | 2019-07-01 | 주식회사 아이젤 | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process |
| KR102036141B1 (en) * | 2017-12-20 | 2019-10-28 | 주식회사 아이젤 | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05310529A (en) | 1993-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220409513A1 (en) | Cosmetic composition for peel-off-type packs, and method for producing same | |
| US3859436A (en) | Sugar composition for topical application | |
| US4999348A (en) | Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions | |
| CA1160955A (en) | Cosmetic cleanser formulation | |
| JPH0587482B2 (en) | ||
| JP3040155B2 (en) | Scrub cleaning fee | |
| JP3176984B2 (en) | Cosmetics | |
| EP3159044B1 (en) | Long-lasting powder essence composition with improved coloring and skin feeling and preparation method thereof | |
| US4393045A (en) | Cosmetic composition | |
| CN114146007A (en) | Double-layer emulsion and preparation method thereof | |
| US4117120A (en) | Medication for herpes simplex and canker sores | |
| CN113081887A (en) | Scalp care shampoo composition with high sea salt content and preparation method thereof | |
| JPS6357508A (en) | Film-forming cosmetic pack | |
| JPS60115506A (en) | Pack | |
| JPH0521085B2 (en) | ||
| JPH0420883B2 (en) | ||
| JPS635011A (en) | Agar film capsule-containing composition for makeup | |
| JP2731845B2 (en) | Transparent gel cosmetic with linear pattern | |
| KR20140074541A (en) | A cosmetic composition containing agar and the preparing method thereof | |
| DE2105110A1 (en) | Novel drug | |
| JP2022011029A (en) | Granular cosmetics and cosmetics containing granular cosmetics | |
| KR20220027633A (en) | Cosmetic Composition Containing LHA Crystal Pearl Effective For Improving Skin Trouble | |
| CA1160958A (en) | Cosmetic toner formulation | |
| DE2405216B2 (en) | Powdered product for antiperspirant agents, process for its manufacture and its use | |
| JPH03240714A (en) | Cosmetic having good moisture-retaining property |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |